http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3upd04_disclose.htm
ATP III Update 2004: Financial Disclosure
Dr. Grundy has received honoraria from Merck, Pfizer, Sankyo, Bayer,
Merck/Schering-Plough, Kos, Abbott, Bristol-Myers Squibb, and
AstraZeneca; he has received research grants from Merck, Abbott, and
Glaxo Smith Kline.
Dr. Cleeman has no financial relationships to disclose.
Dr. Bairey Merz has received lecture honoraria from Pfizer, Merck, and
Kos; she has served as a consultant for Pfizer, Bayer, and EHC
(Merck); she has received unrestricted institutional grants for
Continuing Medical Education from Pfizer, Procter & Gamble, Novartis,
Wyeth, AstraZeneca, and Bristol-Myers Squibb Medical Imaging; she has
received a research grant from Merck; she has stock in Boston
Scientific, IVAX, Eli Lilly, Medtronic, Johnson & Johnson, SCIPIE
Insurance, ATS Medical, and Biosite.
Dr. Brewer has received honoraria from AstraZeneca, Pfizer, Lipid
Sciences, Merck, Merck/Schering-Plough, Fournier, Tularik, Esperion,
and Novartis; he has served as a consultant for AstraZeneca, Pfizer,
Lipid Sciences, Merck, Merck/Schering-Plough, Fournier, Tularik,
Sankyo, and Novartis.
Dr. Clark has received honoraria for educational presentations from
Abbott, AstraZeneca, Bristol-Myers Squibb, Merck, and Pfizer; he has
received grant/research support from Abbott, AstraZeneca,
Bristol-Myers Squibb, Merck, and Pfizer.
Dr. Hunninghake has received honoraria for consulting and speakers
bureau from AstraZeneca, Merck, Merck/Schering-Plough, and Pfizer, and
for consulting from Kos; he has received research grants from
AstraZeneca, Bristol-Myers Squibb, Kos, Merck, Merck/Schering-Plough,
Novartis, and Pfizer.
Dr. Pasternak has served as a speaker for Pfizer, Merck,
Merck/Schering-Plough, Takeda, Kos, BMS-Sanofi, and Novartis; he has
served as a consultant for Merck, Merck/Schering-Plough, Sanofi,
Pfizer Health Solutions, Johnson & Johnson-Merck, and AstraZeneca.
Dr. Smith has received institutional research support from Merck; he
has stock in Medtronic and Johnson & Johnson.
Dr. Stone has received honoraria for educational lectures from Abbott,
AstraZeneca, Bristol-Myers Squibb, Kos, Merck, Merck/Schering-Plough,
Novartis, Pfizer, Reliant, and Sankyo; he has served as a consultant
for Abbott, Merck, Merck/Schering-Plough, Pfizer, and Reliant.
They will all benefit directly by the increase in testing and
treatment of cholesterol.
TC